Back to Journals » Lung Cancer: Targets and Therapy » Volume 4

Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

Total article views   HTML views PDF downloads Totals
9,984 Dovepress* 9,046+ 1,617 10,663
PubMed Central* 938 91 1,029
Totals 9,984 1,708 11,692
*Since 10 June 2013
+Since July 2016

View citations on PubMed Central and Google Scholar